BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/23/2025 8:03:22 AM | Browse: 3 | Download: 16
 |
Received |
|
2025-06-16 07:53 |
|
Peer-Review Started |
|
2025-06-16 07:54 |
|
First Decision by Editorial Office Director |
|
2025-07-10 08:38 |
|
Return for Revision |
|
2025-07-10 08:38 |
|
Revised |
|
2025-07-20 21:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-27 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-28 02:59 |
|
Articles in Press |
|
2025-10-28 02:59 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-15 00:24 |
|
Publish the Manuscript Online |
|
2025-12-23 08:03 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Prospective Study |
| Article Title |
Comparison of parathormone lowering effects of paricalcitol and calcitriol in hemodialysis patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ahmet Murt |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ahmet Murt, Department of Nephrology Clinic, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, No. 53 Kocamustafapaşa Caddesi, Istanbul 34000, Türkiye. ahmet.murt@istanbul.edu.tr |
| Key Words |
Hemodialysis; Parathormone; Calcitriol; Paricalcitol; Vitamin D |
| Core Tip |
Parathormone control has utmost importance for patients undergoing hemodialysis to decrease fracture risk and provide better survival. Although international guidelines recommend keeping parathormone levels between two to nine times of the upper normal limit, new studies provide survival evidence for tighter control. Paricalcitol was found more effective than calcitriol in providing a faster and greater reduction of parathormone. Close monitoring of phosphorus and calcium levels avoided unintended hyperphosphatemia or hypercalcemia with either treatment. |
| Publish Date |
2025-12-23 08:03 |
| Citation |
Murt A. Comparison of parathormone lowering effects of paricalcitol and calcitriol in hemodialysis patients. World J Nephrol 2025; 14(4): 110817 |
| URL |
https://www.wjgnet.com/2220-6124/full/v14/i4/110817.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v14.i4.110817 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
